AbCellera Biologics Inc. financial data

Symbol
ABCL on Nasdaq
Industry
Pharmaceutical Preparations
Location
150 W 4 Th Avenue, Vancouver, British Columbia, Canada
State of incorporation
British Columbia, Canada
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 929 % +11%
Debt-to-equity 28.7 % +4.71%
Return On Equity -14.9 % -20.5%
Return On Assets -11.6 % -19.3%
Operating Margin -1.09K % -75%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 298M shares +1.34%
Common Stock, Shares, Outstanding 296M shares +1.7%
Entity Public Float 671M USD -54.2%
Common Stock, Value, Issued 777M USD +3.18%
Weighted Average Number of Shares Outstanding, Basic 294M shares +1.79%
Weighted Average Number of Shares Outstanding, Diluted 294M shares +1.79%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 28.8M USD -24.2%
Research and Development Expense 167M USD -4.78%
Selling and Marketing Expense 12.8M USD -9.88%
General and Administrative Expense 72.7M USD +19.2%
Operating Income (Loss) -315M USD -32.7%
Nonoperating Income (Expense) 114M USD +81%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -200M USD -15.2%
Income Tax Expense (Benefit) -37.5M USD -35.9%
Net Income (Loss) Attributable to Parent -163M USD -11.2%
Earnings Per Share, Basic -0.55 USD/shares -7.84%
Earnings Per Share, Diluted -0.55 USD/shares -7.84%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 156M USD +17.3%
Cash, Cash Equivalents, and Short-term Investments 626M USD -17.7%
Other Assets, Current 67.1M USD +20.3%
Assets, Current 751M USD -13.8%
Property, Plant and Equipment, Net 277M USD +38.2%
Operating Lease, Right-of-Use Asset 66.6M USD -8.88%
Intangible Assets, Net (Excluding Goodwill) 42.1M USD -65%
Goodwill 47.8M USD 0%
Other Assets, Noncurrent 96.5M USD +2.43%
Assets 1.36B USD -8.57%
Employee-related Liabilities, Current 8.38M USD +8.67%
Contract with Customer, Liability, Current 13.5M USD -28.7%
Liabilities, Current 76.6M USD -35.6%
Contract with Customer, Liability, Noncurrent 5.7M USD -30.4%
Deferred Income Tax Liabilities, Net 10.1M USD -67.2%
Operating Lease, Liability, Noncurrent 60.7M USD -14.7%
Other Liabilities, Noncurrent 1.47M USD -75.1%
Liabilities 304M USD -9.32%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.38M USD -155%
Retained Earnings (Accumulated Deficit) 117M USD -58.2%
Stockholders' Equity Attributable to Parent 1.06B USD -8.35%
Liabilities and Equity 1.36B USD -8.57%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -41.7M USD +5.35%
Net Cash Provided by (Used in) Financing Activities 2.83M USD
Net Cash Provided by (Used in) Investing Activities 29.9M USD
Common Stock, Shares, Issued 296M shares +1.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.75M USD +95%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 181M USD +14.5%
Deferred Tax Assets, Valuation Allowance 49.9M USD +47.5%
Deferred Tax Assets, Gross 104M USD +27.5%
Operating Lease, Liability 65.4M USD -15.5%
Depreciation 12.5M USD -1.73%
Payments to Acquire Property, Plant, and Equipment 24.1M USD +61.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -166M USD -12.8%
Property, Plant and Equipment, Gross 304M USD +40.6%
Operating Lease, Liability, Current 4.62M USD -25%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.88M USD -18.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.82M USD -20.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.78M USD -16.2%
Deferred Tax Assets, Operating Loss Carryforwards 15.6M USD +115%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.82M USD -5.23%
Amortization of Intangible Assets 1.69M USD -36.4%
Share-based Payment Arrangement, Expense 67.6M USD +5.29%